A Tale of Two Markets: Bridging the Gap Between Public and Private Life Sciences Company Valuations

Houlihan Lokey is pleased to present a white paper discussing bridging the gap between public and private life sciences company valuations. In this paper, we will:

  • Explore the ever-evolving landscape of investments in the life sciences sector.
  • Review key trends expected to impact the sector.
  • Discuss methodologies and unique considerations for the valuation of biotech
    companies.
  • Discuss how Houlihan Lokey helps its fund clients navigate private market valuations amid the public market volatility.

*The file is an Adobe Acrobat PDF. If you experience difficulty opening the downloadable file, you may need to download the free Acrobat Reader.

Contact